Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed1
Terminated3

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

58 collaborators·97 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Kuter, MD

Massachusetts General Hospital

Similar
5 trials

Shared therapeutic areas:

Heparin Induced ThrombocytopeniaPurpura, Thrombocytopenic, IdiopathicThrombocytopenia+1 more

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 4 trials
Similarity Score56%

Joseph Kiss, MD

University of Pittsburgh

Moderately Similar
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopeniaPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 3 trials
Similarity Score42%

Ellis Neufeld, MD

Boston Children's Hospital

Moderately Similar
6 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopeniaPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 3 trials
Similarity Score42%

Judith Lin, MD

Brigham and Women's Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Heparin Induced ThrombocytopeniaPurpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 3 trials
Similarity Score42%

Thomas Ortel, MD

Duke University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 2 trials
Similarity Score28%

Nigel Key, MD

University of North Carolina, Chapel Hill

Related
4 trials

Shared therapeutic areas:

Heparin Induced ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Thomas Raife, MD

University of Iowa

Related
3 trials

Shared therapeutic areas:

Heparin Induced ThrombocytopeniaThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Jeffrey McCullough, MD

University of Minnesota

Related
5 trials

Shared therapeutic areas:

ThrombocytopeniaHeparin Induced Thrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Susan F Assmann, PhD

Carelon Research

Related
3 trials

Shared therapeutic areas:

Heparin Induced ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Barbara Konkle, MD

University of Pennsylvania

Related
3 trials

Shared therapeutic areas:

ThrombocytopeniaPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 2 trials
Similarity Score28%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00594685PrincipalInvestigator

Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)

Thrombocytopenia
Terminated
NCT00799773Phase 3PrincipalInvestigator

Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)

Thrombotic Thrombocytopenic Purpura
Terminated
NCT00991939Phase 3PrincipalInvestigator

Initial Treatment of Patients With Immune Thrombocytopenic Purpura

Immune Thrombocytopenic Purpura
Terminated
NCT01178333PrincipalInvestigator

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study

Heparin Induced Thrombocytopenia
Completed

All 4 trials loaded